 |
|
Absence of Antibody to Human Immunodeficiency Virus in Long-term, Socially Rehabilitated Methadone Maintenance Patients
David M. Novick, MD;
Herman Joseph;
T. Scott Croxson, MD;
Edwin A. Salsitz, MD;
Grace Wang, MD;
Beverly L. Richman, MD;
Leonid Poretsky, MD;
Janet B. Keefe, MD, PhD;
Estella Whimbey, MD
Arch Intern Med. 1990;150(1):97-99.
Abstract
• Human immunodeficiency virus (HIV) infection has become widespread among parenteral drug abusers. We measured antibody to HIV and hepatitis B virus markers in 58 long-term, socially rehabilitated methadone-maintained former heroin addicts. None of the 58 had antibody to HIV, but one or more markers of hepatitis B virus infection were seen in 53(91%). The duration of methadone maintenance was 16.9±0.5 years, and the median dose of methadone was 60 mg (range, 5 to 100 mg). Before methadone treatment, the patients had abused heroin parenterally for 10.3±17 years, and they had engaged in additional high-risk practices for HIV infection. We conclude that successful outcomes during methadone maintenance treatment are associated with sparing of parenteral drug abusers from HIV infection.
(Arch Intern Med. 1990;150:97-99)
Author Affiliations
From the Department of Medicine (Drs Novick, Croxson, Salsitz, Poretsky, Keefe, and Whimbey) and the Methadone Maintenance Treatment Program (Dr Richman), Beth Israel Medical Center and Mount Sinai School of Medicine of the City University of New York, the New York State Division of Substance Abuse Services (Mr Joseph), and the Division of Ambulatory Care, St Luke's— Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons (Dr Wang), New York, NY.
Footnotes
Accepted for publication August 8,1989.
Presented in part at the Fifth International Conference on AIDS, Montreal, Canada, June 7,1989.
Reprint requests to Division of Gastroenterology, Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003 (Dr Novick).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT
| FULL TEXT
Pharmacologic Treatment of Heroin-Dependent Patients
O'Connor and Fiellin
ANN INTERN MED 2000;133:40-54.
ABSTRACT
| FULL TEXT
Treatment for Opioid Dependence: Quality and Access
Rounsaville and Kosten
JAMA 2000;283:1337-1339.
FULL TEXT
Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review
Farrell et al.
BMJ 1994;309:997-1001.
FULL TEXT
Advocacy for Methadone Treatment
Newman
ANN INTERN MED 1990;113:819-820.
ABSTRACT
Intravenous Drug Abuse and One Academic Health Center
Dans et al.
JAMA 1990;263:3173-3176.
ABSTRACT
|
